Medicare Benefits Schedule - Item 15900

Search Results for Item 15900

Category 3 - THERAPEUTIC PROCEDURES

15900

15900 - Additional Information

Item Start Date:
01-Sep-2015
Description Updated:
01-Mar-2021
Schedule Fee Updated:
01-Jul-2021

Group
T2 - Radiation Oncology
Subgroup
10 - Targeted Intraoperative Radiotherapy
Subheading
1 - Intraoperative Radiotherapy

BREAST, MALIGNANT TUMOUR, targeted intraoperative radiation therapy, using an Intrabeam® or Xoft® Axxent® device, delivered at the time of breast-conserving surgery (partial mastectomy or lumpectomy) for a patient who:

a) is 45 years of age or more; and

b) has a T1 or small T2 (less than or equal to 3cm in diameter) primary tumour; and

c) has an histologic Grade 1 or 2 tumour; and

d) has an oestrogen-receptor positive tumour; and

e) has a node negative malignancy; and

f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and

g) has no contra-indications to breast irradiation

Applicable only once per breast per lifetime (H)

Fee: $260.10 Benefit: 75% = $195.10


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change